赛托生物(300583) - 2024 Q3 - 季度财报

Financial Performance - The company's revenue for Q3 2024 was ¥198,384,482.30, a decrease of 23.57% compared to the same period last year[2]. - Net profit attributable to shareholders was ¥1,503,955.27, an increase of 26.39% year-over-year, while net profit excluding non-recurring items was ¥457,226.20, down 18.97%[2]. - Total operating revenue for Q3 2024 was CNY 765,034,045.74, a decrease of 17.1% compared to CNY 923,225,289.28 in the same period last year[14]. - Net profit attributable to shareholders of the parent company decreased to CNY 382,178,378.18 from CNY 452,829,022.56, reflecting a decline of 15.5%[13]. - The net profit for Q3 2024 was CNY 13,200,659.89, a significant decrease of 80.5% compared to CNY 67,810,027.16 in the same period last year[15]. - The total profit for the quarter was CNY 20,734,091.03, down 72.9% from CNY 71,710,418.92 year-over-year[15]. - The basic and diluted earnings per share for the quarter were both CNY 0.08, compared to CNY 0.50 in the previous year[16]. - The total comprehensive income attributable to the parent company was CNY 15,812,732.08, down from CNY 58,052,493.70 year-over-year[15]. Assets and Liabilities - The total assets at the end of Q3 2024 were ¥3,087,149,634.98, representing a decrease of 4.72% from the end of the previous year[2]. - The company's total liabilities decreased significantly, with long-term borrowings down by 52.13% to ¥51,862,836.00, reflecting repayment activities[5]. - Total assets as of the end of Q3 2024 were CNY 3,087,149,634.98, down from CNY 3,240,242,403.84 at the end of Q3 2023[13]. - Total liabilities decreased to CNY 1,088,455,759.97 from CNY 1,174,795,832.63, a reduction of 7.3%[13]. - The company's total equity decreased to CNY 1,998,693,875.01 from CNY 2,065,446,571.21, a decline of 3.2%[13]. Cash Flow - The company reported a significant increase in cash flow from operating activities, with a net cash flow of ¥169,011,163.91, up 328.82% year-over-year[6]. - Cash flow from operating activities generated a net inflow of CNY 169,011,163.91, a turnaround from a net outflow of CNY -73,863,271.88 in the same quarter last year[16]. - Cash flow from investing activities resulted in a net outflow of CNY -61,304,458.41, compared to a net outflow of CNY -98,040,979.00 in the previous year[17]. - Cash flow from financing activities showed a net outflow of CNY -191,998,018.10, contrasting with a net inflow of CNY 301,356,757.67 in Q3 2023[17]. Shareholder Information - Total number of common shareholders at the end of the reporting period is 12,375[7]. - The largest shareholder, Shandong Runxin Investment Co., Ltd., holds 22.82% of shares, totaling 43,297,382 shares[7]. - The second-largest shareholder, Mi Chaojie, holds 20.62% of shares, totaling 39,116,800 shares[7]. Operational Metrics - The company experienced a 90.63% increase in receivables financing, totaling ¥211,751,912.67, due to an increase in bank acceptance bills received from customers[5]. - The company reported a 407.05% increase in prepayments, amounting to ¥27,214,522.94, due to increased advance payments for raw materials[5]. - The company has a long-term equity investment of ¥69,490,845.46, an increase from ¥65,119,540.60[11]. - Research and development expenses for Q3 2024 were CNY 41,391,541.00, slightly down from CNY 41,727,262.07 in Q3 2023[14]. Other Financial Highlights - The company received government subsidies totaling ¥1,234,123.51 during the reporting period, contributing to its financial performance[3]. - The company recorded an asset impairment loss of CNY -21,710,361.39 for the quarter[15]. - Other comprehensive income after tax was CNY 1,097,419.76, compared to a loss of CNY -3,433,573.73 in the same period last year[15]. - The company reported a decrease in cash and cash equivalents, reflecting tighter liquidity conditions[12]. - The company's cash and cash equivalents decreased from ¥238,490,756.82 to ¥148,445,436.47, a decline of approximately 37.8%[11]. - Accounts receivable decreased from ¥272,117,151.74 to ¥226,439,613.49, a decline of about 16.8%[11]. - Inventory decreased from ¥722,624,129.92 to ¥690,194,330.29, a decline of approximately 4.5%[11]. - Non-current assets, including fixed assets, decreased from ¥1,266,998,561.61 to ¥1,119,845,035.90, a decline of about 11.6%[11]. Future Outlook - The company plans to focus on market expansion and new product development in the upcoming quarters[12]. - The company is exploring potential mergers and acquisitions to enhance its market position and product offerings[12]. - The company has no new product or technology developments mentioned in the report[10].